This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Canine Myo-inositol Oxygenase (MIOX) Monoclonal Antibody
Product Overview
BioVenic mouse monoclonal antibody is specific for canine myo-inositol oxygenase. It can be applied to WB, ICC/IF, IHC and FACS assays of canine myo-inositol oxygenase.
Specifications
Target Information
Canine myo-inositol oxygenase (MIOX) is a non-heme di-iron oxygenase enzyme located in the kidney, primarily responsible for the catabolism of myo-inositol, a key component in cellular membrane turnover and osmoregulation. MIOX plays a crucial role in glucose and lipid metabolism, as well as in the regulation of insulin secretion from pancreatic beta-cells, thereby influencing the glucose and lipid metabolism in insulin-sensitive tissues such as liver, muscle, and adipose tissues. It is also involved in the conversion of myo-inositol to D-chiro-inositol, which is important for various metabolic pathways. The activity of MIOX is implicated in the excretion of inositol in urine, which can serve as a biomarker for metabolic disruptions, including diabetic kidney disease. Understanding MIOX's function in dogs is essential for managing metabolic health and could provide insights into therapeutic targets for restoring myo-inositol levels and improving metabolic outcomes.
Shipping and Storage
This product is shipped with wet ice packs. Store at -20°C on receipt (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.